Medications
What does the new personalized cancer medicine approved in England mean for patients?
Today, a new personalized cancer treatment was approved for NHS use in England.
Apr 22, 2020
0
3
News tagged with larotrectinib
Oncology & Cancer
FDA approves Vitrakvi for cancers with certain genetic trait
(HealthDay)—Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific genetic feature.
Nov 28, 2018
0
25
Oncology & Cancer
Kinase inhibitor larotrectinib shows durable anti-tumor abilities
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...
Feb 21, 2018
0
51
Oncology & Cancer
Larotrectinib in tumours with NTRK gene fusion: Data are not yet sufficient
In the summer of 2019, larotrectinib was approved as the first drug in Europe to be used in numerous different solid tumours if the tumour tissue displays a so-called NTRK gene fusion. Since such a fusion of a neurotrophic ...
Jan 16, 2020
0
1
